Literature DB >> 3282307

Independent molecular pathways in initiation and loss of hormone responsiveness of breast carcinomas.

S Sukumar1, W P Carney, M Barbacid.   

Abstract

These studies were set up to determine whether those oncogenes participating in the initiation of mammary carcinogenesis (for example, ras oncogenes) play a direct role in the outcome of events associated with the late stages of tumor development such as loss of hormone dependency. Mammary carcinomas induced by a single carcinogenic insult in pubescent rats was selected as an in vivo model system with direct relevance to human breast cancer. Acquisition of hormone-independent growth in these carcinogen-induced tumors was found to be independent of the activation of ras oncogenes during the early stages of carcinogenesis. In agreement with these observations, introduction of a human ras oncogene into human MCF-7 breast carcinoma cells did not abrogate their hormonal dependency for growth in vivo. These findings suggest that those events responsible for the critical stages of breast cancer development occur independently and in an uncoordinated manner.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3282307     DOI: 10.1126/science.3282307

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  14 in total

Review 1.  Expression of activated oncogenes in the murine mammary gland: transgenic models for human breast cancer.

Authors:  W J Muller
Journal:  Cancer Metastasis Rev       Date:  1991-10       Impact factor: 9.264

2.  Specific patterns of oncogene activation in transplacentally induced tumors.

Authors:  S Sukumar; M Barbacid
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

3.  Mammary carcinogenesis induced by N-methyl-N-nitrosourea (MNU) and medroxyprogesterone acetate (MPA) in BALB/c mice.

Authors:  P Pazos; C Lanari; R Meiss; E H Charreau; C D Pasqualini
Journal:  Breast Cancer Res Treat       Date:  1992-01       Impact factor: 4.872

Review 4.  Aberrant function of the Ras signal transduction pathway in human breast cancer.

Authors:  G J Clark; C J Der
Journal:  Breast Cancer Res Treat       Date:  1995-07       Impact factor: 4.872

Review 5.  William L. McGuire Memorial Symposium. Drug resistance to tamoxifen during breast cancer therapy.

Authors:  D M Wolf; V C Jordan
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

6.  Exposure, susceptibility, and breast cancer risk: a hypothesis regarding exogenous carcinogens, breast tissue development, and social gradients, including black/white differences, in breast cancer incidence.

Authors:  N Krieger
Journal:  Breast Cancer Res Treat       Date:  1989-07       Impact factor: 4.872

7.  Progression of interleukin-2 (IL-2)-dependent rat T cell lymphoma lines to IL-2-independent growth following activation of a gene (Gfi-1) encoding a novel zinc finger protein.

Authors:  C B Gilks; S E Bear; H L Grimes; P N Tsichlis
Journal:  Mol Cell Biol       Date:  1993-03       Impact factor: 4.272

8.  The 5' flanking region of the pS2 gene contains a complex enhancer region responsive to oestrogens, epidermal growth factor, a tumour promoter (TPA), the c-Ha-ras oncoprotein and the c-jun protein.

Authors:  A M Nunez; M Berry; J L Imler; P Chambon
Journal:  EMBO J       Date:  1989-03       Impact factor: 11.598

Review 9.  The ras signaling pathway in mammary tumorigenesis and metastasis.

Authors:  S Malaney; R J Daly
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-01       Impact factor: 2.698

10.  cDNA transfection followed by the isolation of a MCF-7 breast cell line resistant to tamoxifen in vitro and in vivo.

Authors:  M Toi; A L Harris; R Bicknell
Journal:  Br J Cancer       Date:  1993-12       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.